Halozyme Therapeutics

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Dickson achieves ISO 14001 certification ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
  5. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and...

Upcoming event

Interphex

16-18 April 2024 | Conference and Exhibition | New York, US See all

Related Content

Manufacturing

What’s in a partner? The essential facets of a strong biopharma collaboration

Partnerships are an essential aspect of biopharmaceutical manufacturing, enabling the industry to create therapeutics for patients that meet the fundamental criteria of safety, efficacy and quality, reports  Dr Michael LaBarre, Chief Technical Officer at Halozyme
Regulatory

Halozyme announces first clinical dosing of Pfizer's rivipansel using Enhanze technology

First healthy subject dosed in Halozyme collaboration with Pfizer
Research & Development

Michael Labarre becomes Chief Scientific Officer at Halozyme Therapeutics

His career in biotech drug discovery and development spans two decades
Subscribe now